Sponsor Pipeline

PharmaBio Corporation Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
Active Trials by Phase
Not specified
3
Active Trials
NCT IDTitleConditionStatus
Not specified
NCT07005323 Progression Suppression and Retinal Regression in VEGF-resistant AMD Neovascular Age-related Macular Degeneration (AMD) Recruiting
NCT07016438 Clinical Study of PAL-222 Targeting Patients With Refractory Skin Ulcer Refractory Skin Ulcer Recruiting
NCT05658237 Clinical Study of PAL-222 Targeting Patients With Myopic Chorioretinal Atrophy (PAMyCA) Myopic Chorioretinal Atrophy Active, Not Recruiting
Get alerts when PharmaBio Corporation's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free